Evidence map›Paper›PMID 33172983›Full record

ArticleJournal of cell science2020

Dopamine D1 receptor stimulates cathepsin K-dependent degradation and resorption of collagen I in lung fibroblasts.

Ana M Diaz-Espinosa, Patrick A Link, Delphine Sicard, Ignasi Jorba, Daniel J Tschumperlin, Andrew J Haak

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  4. Review
  5. Loss of lung mesenchymal identities in culture and a screening approach to identify restorative cues.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  6. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary.American journal of respiratory cell and molecular biology · 2025
    Article
  7. Dopamine receptors and organ fibrosis.Biochemistry and biophysics reports · 2025
    Review
  8. A Redox-Shifted Fibroblast Subpopulation Emerges in the Fibrotic Lung.American journal of respiratory cell and molecular biology · 2024
    Article
  9. Dopamine Receptor D1 Is Exempt from Transforming Growth FactorThe Journal of pharmacology and experimental therapeutics · 2023
    Article
  10. Mechanoepigenetic regulation of extracellular matrix homeostasis via Yap and Taz.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. The Chemistry and Biology of Collagen Hybridization.Journal of the American Chemical Society · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana M Diaz-EspinosaDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
Patrick A LinkDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
Delphine SicardDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
Ignasi JorbaDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-6434-1021
Daniel J TschumperlinDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-5115-9025
Andrew J HaakDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA haak.andrew@mayo.edu.ORCID 0000-0002-5323-253X
Mayo Clinic · US

Funding

Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
Interdisciplinary Training in Lung Physiology and Biomedical EngineeringT32HL105355 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2012 to 2021
$3.9M
Targeting matrix stiffness in lung and liver fibrosisR01HL133320 · NHLBI · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H., TSCHUMPERLIN, DANIEL J. · 2016 to 2019
$2.2M
NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R01 HL133320NHLBI NIH HHS T32 HL105355
6 · The paper itself

Abstract

Matrix resorption is essential to the clearance of the extracellular matrix (ECM) after normal wound healing. A disruption in these processes constitutes a main component of fibrotic diseases, characterized by excess deposition and diminished clearance of fibrillar ECM proteins, such as collagen type I. The mechanisms and stimuli regulating ECM resorption in the lung remain poorly understood. Recently, agonism of dopamine receptor D1 (DRD1), which is predominantly expressed on fibroblasts in the lung, has been shown to accelerate tissue repair and clearance of ECM following bleomycin injury in mice. Therefore, we investigated whether DRD1 receptor signaling promotes the degradation of collagen type I by lung fibroblasts. For cultured fibroblasts, we found that DRD1 agonism enhances extracellular cleavage, internalization and lysosomal degradation of collagen I mediated by cathepsin K, which results in reduced stiffness of cell-derived matrices, as measured by atomic force microscopy.

Indexed as

Collagen Type IFibroblastsAnimalsCathepsin KCells, CulturedCollagenExtracellular MatrixLungMiceReceptors, Dopamine D1Cathepsin KCollagenCollagen Type IReceptors, Dopamine D1Cathepsin KDopamine receptorFibrosisResolutionResorption

Identifiers

PMID33172983
PMCPMC7746663
OpenAlexW3102913230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.